XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
UNAUDITED CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Subscription Receivable [Member]
Additional Paid-In Capital
Accumulated Deficit
Other Comprehensive Income / Loss
Sub Total [Member]
Noncontrolling Interest
Total
Beginning balance, shares at Jul. 31, 2019 78,608,419              
Beginning balance, value at Jul. 31, 2019 $ 78,608 $ 408,550,211 $ (418,727,875) $ 797,216 $ (9,301,840) $ 16,974,439 $ 7,672,599
Shares issued for deferred offering, shares 1,719,901              
Shares issued for deferred offering, value $ 1,720 (767,690) 765,970
Stock compensation expense 1,630,111 1,630,111 1,630,111
Shares issued for services, shares 669,803              
Shares issued for services, value $ 670 292,930 293,600 293,600
Issuance of common stock payable, shares 436,121              
Issuance of common stock payable, value $ 436 935,959 936,395 936,395
Conversion of debt to equity, shares 9,719,740              
Conversion of debt to equity, value $ 9,720 4,480,190 4,489,910 4,489,910
Issuance of common stock for acquisitions, shares 960,000              
Issuance of common stock for acquisitions, value $ 960 1,150,992 1,151,952 1,151,952
Reduction of derivative liabilities 3,041,502 3,041,502 3,041,502
Cancellation of shares, shares (20,375,900)              
Cancellation of shares, value $ (20,376) 20,376
Purchase of shares in subsidiary, shares 7,855,912              
Purchase of shares in subsidiary, value $ 7,856 6,571,811 6,579,667 (6,579,667)
Shares issued as debt issuance cost, shares 343,000              
Shares issued as debt issuance cost, value $ 343 150,887 151,230 151,230
Currency translation adjustment (4,983) (4,983) (4,983)
Settlement of subsidiary's debt with stock 32,212 32,212 32,212
Net Income (Loss) (21,661,910) (21,661,910) (691,484) (22,353,394)
Ending balance, shares at Apr. 30, 2020 79,936,996              
Ending balance, vlaue at Apr. 30, 2020 $ 79,937 (767,690) 427,623,151 (440,389,785) 792,233 (12,662,155) 9,703,288 (2,958,866)
Beginning balance, shares at Jan. 31, 2020 69,129,001              
Beginning balance, value at Jan. 31, 2020 $ 69,127 (767,690) 420,206,242 (434,763,323) 775,191 (14,480,453) 14,429,920 (50,533)
Stock compensation expense 393,414 393,414 393,414
Shares issued for services, shares 109,803              
Shares issued for services, value $ 110 49,890 50,000 50,000
Conversion of debt to equity, shares 4,713,192              
Conversion of debt to equity, value $ 4,715 1,580,437 1,585,152 1,585,152
Reduction of derivative liabilities 765,424 765,424 765,424
Purchase of shares in subsidiary, shares 5,950,000              
Purchase of shares in subsidiary, value $ 5,950 4,586,327 4,592,277 (4,592,277)
Shares issued as debt issuance cost, shares 35,000              
Shares issued as debt issuance cost, value $ 35 9,205 9,240 9,240
Currency translation adjustment 17,042 17,042 17,042
Settlement of subsidiary's debt with stock 32,212 32,212 32,212
Net Income (Loss) (5,626,462) (5,626,462) (134,355) (5,760,817)
Ending balance, shares at Apr. 30, 2020 79,936,996              
Ending balance, vlaue at Apr. 30, 2020 $ 79,937 (767,690) 427,623,151 (440,389,785) 792,233 (12,662,155) 9,703,288 (2,958,866)
Beginning balance, shares at Jul. 31, 2020 82,251,801              
Beginning balance, value at Jul. 31, 2020 $ 82,251 429,744,379 (452,062,905) 780,296 (21,455,979) 9,497,709 (11,958,270)
Stock compensation expense 2,160,788 2,160,788 2,160,788
Issuance of common stock as offering costs, shares 284,900              
Issuance of common stock as offering costs, value $ 285 (285)
Shares issued for services, shares 51,130              
Shares issued for services, value $ 51 10,942 10,993 10,993
Issuance of common stock payable, shares 3,529,415              
Issuance of common stock payable, value $ 3,529 1,469,297 1,472,826 1,472,826
Conversion of debt to equity, shares 7,665,359              
Conversion of debt to equity, value $ 7,665 1,610,939 1,618,604 1,618,604
Reduction of derivative liabilities 575,987 575,987 575,987
Issuance of common stock and warrants with attributed derivative liability from PIPE offering, shares 5,102,040              
Issuance of common stock and warrants with attributed derivative liability from PIPE offering, value $ 5,102 (19,729,318) (19,724,216) (19,724,216)
Deemed dividend related to issuance of warrants containing derivative liabilities 1,850,000 (1,850,000)
Settlement of derivative liability from exercise of warrants 1,840,530 1,840,530 1,840,530
Issuance of common stock, net of fees, shares 7,700,000              
Issuance of common stock, net of fees, value $ 7,700 1,846,557 1,854,257 1,854,257
Exercise of warrants, shares 9,142,973              
Exercise of warrants, value $ 9,143 9,143 9,143
Shares issued as debt issuance cost, shares 551,072              
Shares issued as debt issuance cost, value $ 551 178,280 178,831 178,831
Warrants granted with notes payable 740,028 740,028 740,028
Currency translation adjustment (26,487) (26,487) (26,487)
Net Income (Loss) (25,588,724) (25,588,724) (1,321,639) (26,910,363)
Ending balance, shares at Apr. 30, 2021 116,278,690              
Ending balance, vlaue at Apr. 30, 2021 $ 116,277 422,298,124 (479,501,629) 753,809 (56,333,419) 8,176,070 (48,157,349)
Beginning balance, shares at Jan. 31, 2021 112,572,514              
Beginning balance, value at Jan. 31, 2021 $ 112,572 (275,324) 420,021,103 (488,724,179) 766,038 (68,099,790) 8,913,286 (59,186,504)
Stock compensation expense 418,738 418,738 418,738
Issuance of common stock, shares 1,350,000              
Issuance of common stock, value $ 1,350 412,967 414,317 414,317
Conversion of debt to equity, shares 1,805,104              
Conversion of debt to equity, value $ 1,804 488,957 490,761 490,761
Reduction of derivative liabilities   38,051 38,051   38,051
Subscription receivable, value   275,324 275,324   275,324
Shares issued as debt issuance cost, shares 551,072              
Shares issued as debt issuance cost, value $ 551 178,280 178,831 178,831
Warrants granted with notes payable 740,028 740,028 740,028
Currency translation adjustment (12,229) (12,229) (12,229)
Net Income (Loss) 9,222,550 9,222,550 (737,216) 8,485,335
Ending balance, shares at Apr. 30, 2021 116,278,690              
Ending balance, vlaue at Apr. 30, 2021 $ 116,277 $ 422,298,124 $ (479,501,629) $ 753,809 $ (56,333,419) $ 8,176,070 $ (48,157,349)